Status | Study |
Withdrawn |
Study Name: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction Condition: Mixed Hyperlipoproteinemia Date: 2014-02-20 Interventions: Dietary Supplement: Pro-Omega LDL Other: P |
Completed |
Study Name: A Pilot Study to Evaluate the Lipid Effects of TRIA-662 Condition: Hypertriglyceridemia Mixed Hyperlipidemia Date: 2013-12-06 Interventions: Drug: TRIA-662 Following Basel |
Withdrawn |
Study Name: Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid Condition: Mixed Hyperlipidemia Date: 2013-10-25 Interventions: Drug: Atorvastatin 10mg, fenofibric acid 135mg |
Completed |
Study Name: Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) Condition: Primary Hypercholesterolemia Mixed Hyperlipidemia Date: 2009-07-16 Interventions: Drug: SCH 900271 15mg oral tab |
Completed |
Study Name: Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients Condition: Hypertriglyceridemia Hyperlipoproteinemia Type IV Date: 2007-05-14 Interventions: Drug: rosuvastatin 10mg or 20mg |
Terminated |
Study Name: MK0859 Dose-Ranging Study (0859-003) Condition: Hypercholesterolemia Mixed Hyperlipemia Date: 2006-05-11 Interventions: Drug: MK0859 |
Completed |
Study Name: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) Condition: Mixed Hyperlipidemia Date: 2006-02-07 Interventions: Drug: MK-0524A Drug: Atorvastatin |
Completed |
Study Name: Lipid Efficacy Study (0524B-022)(COMPLETED) Condition: Primary Hypercholesterolemia Mixed Hyperlipidemia Date: 2005-12-21 Interventions: Drug: niacin (+) laropiprant (+) simvastatin |
Completed |
Study Name: Lipid Efficacy/Tolerability Study (0524A-020) Condition: Primary Hypercholesterolaemia Mixed Hyperlipidaemia Date: 2005-12-21 Interventions: Drug: niacin (+) laropiprant D |
Terminated |
Study Name: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. Condition: Mixed Hyperlipidemia Date: 2005-08-22 Interventions: Drug: torcetrapib/atorvastatin Drug: atorv |